spacer
spacer

PDBsum entry 2qpf

Go to PDB code: 
protein Protein-protein interface(s) links
Transport protein PDB id
2qpf

 

 

 

 

Loading ...

 
JSmol PyMol  
Contents
Protein chains
(+ 2 more) 117 a.a. *
Waters ×347
* Residue conservation analysis
PDB id:
2qpf
Name: Transport protein
Title: Crystal structure of mouse transthyretin
Structure: Transthyretin. Chain: a, b, c, d, e, f, g, h. Synonym: prealbumin. Engineered: yes
Source: Mus musculus. House mouse. Organism_taxid: 10090. Gene: ttr. Expressed in: escherichia coli. Expression_system_taxid: 562.
Resolution:
2.05Å     R-factor:   0.200     R-free:   0.246
Authors: N.Reixach,T.R.Foss,E.Santelli,J.Pascual,J.W.Kelly,J.N.Buxbaum
Key ref:
N.Reixach et al. (2008). Human-Murine Transthyretin Heterotetramers Are Kinetically Stable and Non-amyloidogenic: A LESSON IN THE GENERATION OF TRANSGENIC MODELS OF DISEASES INVOLVING OLIGOMERIC PROTEINS. J Biol Chem, 283, 2098-2107. PubMed id: 18006495 DOI: 10.1074/jbc.M708028200
Date:
23-Jul-07     Release date:   27-Nov-07    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chains
Pfam   ArchSchema ?
P07309  (TTHY_MOUSE) -  Transthyretin from Mus musculus
Seq:
Struc:
147 a.a.
117 a.a.*
Key:    PfamA domain  Secondary structure  CATH domain
* PDB and UniProt seqs differ at 1 residue position (black cross)

 

 
DOI no: 10.1074/jbc.M708028200 J Biol Chem 283:2098-2107 (2008)
PubMed id: 18006495  
 
 
Human-Murine Transthyretin Heterotetramers Are Kinetically Stable and Non-amyloidogenic: A LESSON IN THE GENERATION OF TRANSGENIC MODELS OF DISEASES INVOLVING OLIGOMERIC PROTEINS.
N.Reixach, T.R.Foss, E.Santelli, J.Pascual, J.W.Kelly, J.N.Buxbaum.
 
  ABSTRACT  
 
The transthyretin amyloidoses appear to be caused by rate-limiting tetramer dissociation and partial monomer unfolding of the human serum protein transthyretin, resulting in aggregation and extracellular deposition of amorphous aggregates and amyloid fibrils. Mice transgenic for few copies of amyloid-prone human transthyretin variants, including the aggressive L55P mutant, failed to develop deposits. Silencing the murine transthyretin gene in the presence of the L55P human gene resulted in enhanced tissue deposition. To test the hypothesis that the murine protein interacted with human transthyretin, preventing the dissociation and partial unfolding required for amyloidogenesis, we produced recombinant murine transthyretin and human/murine transthyretin heterotetramers and compared their structures and biophysical properties to recombinant human transthyretin. We found no significant differences between the crystal structures of murine and human homotetramers. Murine transthyretin is not amyloidogenic because the native homotetramer is kinetically stable under physiologic conditions and cannot dissociate into partially unfolded monomers, the misfolding and aggregation precursor. Heterotetramers composed of murine and human subunits are also kinetically stable. These observations explain the lack of transthyretin deposition in transgenics carrying a low copy number of human transthyretin genes. The incorporation of mouse subunits into tetramers otherwise composed of human amyloid-prone transthyretin subunits imposes kinetic stability, preventing dissociation and subsequent amyloidogenesis.
 
  Selected figure(s)  
 
Figure 1.
FIGURE 1. A, primary structure alignment of Hu-TTR and Mu-TTR. Stars at the bottom indicate identical amino acid residues. B, two views of the crystal structure of Mu-TTR superimposed on that of Hu-TTR. Each mouse TTR subunit is shown in a different color; Hu-TTR is shown in gray. Dashed lines indicate the dimer interfaces, and the crystallographic C[2] x axis is labeled.
Figure 4.
FIGURE 4. Kinetics of tetramer disassembly (closed symbols) and unfolding (open symbols) in 6 M urea for Hu-TTR (triangles) and Mu-TTR (circles). For both Hu-TTR and Mu-TTR the loss of quaternary structure (disassembly) and the loss of tertiary structure (unfolding) are tightly linked. Mu-TTR is kinetically stabilized compared with Hu-TTR as seen by its significantly slower dissociation/unfolding kinetics. Tetramer disassembly was measured by resveratrol binding fluorescence; unfolding was measured by tryptophan fluorescence.
 
  The above figures are reprinted by permission from the ASBMB: J Biol Chem (2008, 283, 2098-2107) copyright 2008.  
  Figures were selected by the author.  

Literature references that cite this PDB file's key reference

  PubMed id Reference
21203571 J.Zrimi, A.Ng Ling, E.Giri-Rachman Arifin, G.Feverati, and C.Lesieur (2010).
Cholera toxin B subunits assemble into pentamers--proposition of a fly-casting mechanism.
  PLoS One, 5, e15347.  
19627988 J.N.Buxbaum (2009).
Animal models of human amyloidoses: are transgenic mice worth the time and trouble?
  FEBS Lett, 583, 2663-2673.  
19602727 L.Cendron, A.Trovato, F.Seno, C.Folli, B.Alfieri, G.Zanotti, and R.Berni (2009).
Amyloidogenic potential of transthyretin variants: insights from structural and computational analyses.
  J Biol Chem, 284, 25832-25841.  
19725883 P.Prapunpoj, and L.Leelawatwattana (2009).
Evolutionary changes to transthyretin: structure-function relationships.
  FEBS J, 276, 5330-5341.  
19125186 T.Mairal, J.Nieto, M.Pinto, M.R.Almeida, L.Gales, A.Ballesteros, J.Barluenga, J.J.Pérez, J.T.Vázquez, N.B.Centeno, M.J.Saraiva, A.M.Damas, A.Planas, G.Arsequell, and G.Valencia (2009).
Iodine atoms: a new molecular feature for the design of potent transthyretin fibrillogenesis inhibitors.
  PLoS ONE, 4, e4124.
PDB codes: 3fc8 3fcb
The most recent references are shown first. Citation data come partly from CiteXplore and partly from an automated harvesting procedure. Note that this is likely to be only a partial list as not all journals are covered by either method. However, we are continually building up the citation data so more and more references will be included with time. Where a reference describes a PDB structure, the PDB codes are shown on the right.

 

spacer

spacer